Nurse Practitioner, Primary Care · Rome, GA
NPI
1245271022
Since 2006
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
420 E 2nd Ave, Suite 103
Rome, GA, 30161
Phone (706) 509-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
1,126 services
Medicare patients, 2024
155
Average age 72
Drug cost, 2024
$3.1M
5,451 prescriptions
Company payments, 2025
$48.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Donna F Childers was code 83036 (blood count), 323 times for 138 patients. In total Donna F Childers billed 1,126 services in 12 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83036 Blood Count | Office | 323 | 138 | $9.24 | $2,985 |
| 99213 Office E&M - Established | Office | 280 | 125 | $48.74 | $14K |
| 95251 Test - Miscellaneous | Office | 194 | 73 | $19.13 | $3,711 |
| 99214 Office E&M - Established | Office | 150 | 88 | $65.56 | $9,834 |
| 36415 Venipuncture Blood Collection | Office | 142 | 86 | $8.47 | $1,202 |
By year: 2022 $39K for 1,438 services; 2023 $32K for 1,055 services; 2024 $33K for 1,126 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 323 | 138 | $9.24 | $2,985 |
| 36415 Venipuncture Blood Collection | 142 | 86 | $8.47 | $1,202 |
Medicare prescription drug claims, 2024
In 2024, the drug Donna F Childers prescribed most often to Medicare patients was Ozempic (Semaglutide), with 463 prescriptions and refills. In total Donna F Childers wrote 5,451 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 463 | 622 | 85 | $578K |
| Mounjaro Tirzepatide | 309 | 386 | 53 | $413K |
| Tresiba Flextouch U-100 Insulin Degludec | 298 | 588 | 71 | $199K |
| Farxiga Dapagliflozin Propanediol | 293 | 480 | 72 | $270K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 287 | 580 | 72 | $47K |
| Humalog Kwikpen U-100 Insulin Lispro | 286 | 571 | 86 | $89K |
| Metformin Hcl Generic | 245 | 656 | 70 | $1,998 |
| Jardiance Empagliflozin | 217 | 375 | 47 | $215K |
| Novolog Flexpen Insulin Aspart | 180 | 320 | 53 | $56K |
| Atorvastatin Calcium Generic | 163 | 457 | 49 | $1,300 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 152 | 353 | 47 | $113K |
| Levothyroxine Sodium Generic | 150 | 418 | 42 | $2,161 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 144 | 318 | 49 | $16K |
| Metformin Hcl Er Metformin Hcl | 129 | 340 | 41 | $1,380 |
| Tresiba Flextouch U-200 Insulin Degludec | 112 | 191 | 25 | $171K |
Brand drugs: 3,720 claims; generic drugs: 1,048 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Donna F Childers $48.75 ($48.75 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $48.75.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 2 | $48.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.